Value of immunohistochemistry in the detection of <i>BRAF^V600E</i> mutations in fine‐needle aspiration biopsies of papillary thyroid carcinoma

Abstract

BRAF(V600E) mutations in FNAB specimens from patients with PTC can be reliably detected in most cases by IHC with a new mutation-specific antibody. Interpretation of VE1 IHC staining results on cell block slides of PTC can be difficult in some cases.